Queen's University

School of

Graduate Studies

School of

Graduate Studies

site header
Subscribe to RSS - News

Alison Michels - Searching for links between hemostasis and innate immunity

MD/PhD student Alison Michels studies the von Willebrand factor (VWF), which is a glycoprotein involved in platelet adhesion and functions as a carrier protein for the coagulation factor VIII. It received such an "aristocratic" name from the Finnish physician and researcher Erik Adolf von Willebrand, who focused on properties of blood and its coagulation. An imbalance in VWF is associated with abnormal hemostasis that can manifest in bleeding and thrombotic cardiovascular disease.

Tags: 

Winning Big: Bailey Gerrits receives prestigious Trudeau Scholarship

Bailey Gerrits, a PhD student in Political Studies under the supervision of Elizabeth Goodyear-Grant and Margaret Little, is one of 16 recipients of the award across Canada this year. "It means a lot in that I think it's a booster in confidence around the research topic and my ability to sell it to them as something that matters to the world", says Gerrits.

The Trudeau scholarship is the most prestigious Canadian award of its type. Gerrits had to present her research to a panel of four in an in-person interview after she was short listed for the award. "It was a challenge and I think a really positive challenge to try to communicate to an audience and saying this matter to you," adds Gerrits.

Tags: 

Sarah Rampersad - Understanding the Exchange of Bio-Messages

Sarah Rampersad, a fourth-year PhD candidate at Queen’s, investigates peculiar substances that simply do not exist for most people, because they cannot be seen with the naked eye. “Generally, my research is related to the problem of atherosclerosis, which can result in heart attacks and strokes, unfortunately”, Sarah says, “and I examine such threatening conditions through the lens of biochemistry and cell biology.”

Tags: 

Donya Danesh - Getting to the core of climate change in an ecotone?

Donya Danesh’s PhD work in paleolimnology on a subfield with only a few remaining experts in the world has taken her from the deepest parts of remote Northwest Ontario lakes to the shores of an old world city (Amsterdam), to visit two of those experts at the Paleo Ecology and Landscape Ecology Group at the Institute of Biodiversity and Ecosystem Dynamics (IBED) at University of Amsterdam. 

Tags: 

Yulei Zhao - Conquering Drug Resistance in Cancer Patients

Yulei is currently researching human resistance to anti-tubulin drugs, which are widely used for the clinical chemotherapy treatment of various cancers. For example, 30-68% of related cancer patients have an intrinsic resistance to Taxol, one of the most commonly-used clinical anti-tubulin drugs, and 70-80% of the patients develop an acquired resistance over the course of the treatment. Resistance, whether it is intrinsic or acquired, always results in failure of the treatment. This is a significant issue because, despite the treatments, the cancer will reoccur and contribute to the high mortality rates of cancer patients. Identifying the molecules that are involved in anti-tubulin drugs resistance may be the key to solving resistance issues.

Tags: 

Destination Kingston: Building an Innovation Cluster

July 9, 2015

The first Science to Business Network event, in partnership with Life Sciences Ontario (LSO), was recently held at Queen’s University. The President and founder of the Science to Business (or S2B) Network, Dr. Bruce Seet, started the network to enhance Canada’s culture of innovation and its entrepreneurial ecosystem. S2B has been steadily gaining steam through networking events, educational programs, and workshops since 2011 with the ultimate goal of optimizing the science to business transition for graduate stude

Tags: 

Pages